ISSN: 2754-5008 | Open Access

Journal of Pharmaceutical Research & Reports

Guidelines for Authors

Journal of Pharmaceutical Research & Reports is an Open Access Peer review Journal from Scientific Research and Community Publishers publish all research articles, Video articles and Power Point presentations in the arena of Pharmaceutical studies will always be freely available online and readily accessible.

Articles are accepted in the form Research, Review, Case Reports, Analysis, Magazines, Editorials, Opinion, Communications, Mini-review, Short Communications, Image, Book review, Video articles and Power point presentations (PPTS).

You may submit articles through online: http://www.onlinescientificresearch.com/submit-online.php (or) you may send the article as an email attachment to pharmaceutics@onlinescientificresearch.info

Open Access Policy
Research papers published both in electronic and print versions may be freely viewed/ copied/ and printed by individual academicians and researchers

Disclaimer
Management disclaims any responsibility for the statements and opinion offered by the author/s in article/s. No material in any form can be reproduced without permission of Scientific Research and Community.

This manuscript is based on original work and had not been published in whole or part, in any print or electronic media or is under consideration of publication in any print or electronic media other than as abstract of conference proceedings. Persons designated as authors must meet all of the following criteria.

Preparation of Manuscripts
Manuscripts should consist of the following subdivisions: Title page, Abstract, Introduction, Materials and Methods, Results/Observations, Discussion, Acknowledgements, References, Tables, Figures and Legends. All manuscripts should be written in English and number all the pages consecutively beginning with the title page.

The original copy of the manuscript along with figures should be sent to the editorial  online at  or as an email attachment to above given email-id's

No need to send hard copies of the manuscripts if they have already been sent through e-mail

Title Page
The title page should include the complete title of the manuscript, the author(s) name(s), address of the institute where the work was conducted, running title and the name and address of the author to whom the correspondence should be sent; 3-8 key words must be included.

Abstract
The abstract should not exceed 250 words. It should be written in complete sentences and should give factual information.

Abbreviations
Abbreviations of units should conform to those shown below:

Other abbreviations and symbols should follow the recommendations on units, symbols and abbreviations: in “A guide for Biological and Medical Editors and Authors (The Royal Society of Medicine London 1977)”.

References
A list of all the references cited in the text should be given at the end of the manuscript. The references should be cited according to the vancover agreement. They should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in the text by Arabic numerals [in square brackets]. Authors must check and ensure the accuracy of all references cited. All authors should be cited. Abbreviations of titles of medical periodicals should conform to those used in the latest edition of Index Medicus. The volume of the periodical should be followed by the page number of each reference cited. Some examples are shown below:

Journal article
Tang L, Zhou XD, Wang Y, Zhang L, Zheng QH, Huang DM (2011) Detection of vertical root fracture using cone beam computed tomography: Report of two cases. J Pharma Res Rep ; 27: 484-8.

Tables
Do not submit tables as photographs or scanned documents. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. The tables should be typed on separate sheets. Place explanatory details as footnotes. Give each column a short or abbreviated heading.

Figures
All figures should be listed together. Figures should not exceed 16.5 x 22.0 cm and should be numbered. For the reproduction of illustrations, only good quality drawings and original photographs can be accepted. When possible, group several illustrations on one page for reproduction. Photomicrographs should have internal scale markers. Symbols, arrows, or letters used in the photomicrographs should contrast with the back­ground. Electronically submitted b/w half-tone and colour illustrations must have a final resolution of 300 dpi after scaling, and 800-1200 dpi for line drawings.

Fee Policy
Once an article has been accepted for publication, any Article Processing Charges become due towards the time and resources utilized in processing the article. The submitting author assumes responsibility for the Article Processing Charges USD $3619 and also once a payment is processed, the journal will not issue refunds of any kind.

Galley Proofs
Unless indicated otherwise, galley proofs will be sent to the first-named author and should be returned within 48 hours of receipt.

Corrections, Retractions & Expressions of Concern

In an effort to better serve our researchers, librarians, and others in the academic community, Journal of Pharmaceutical Research & Reports believes clarity in the publishing record is a critical component of information distribution. Recognizing a published article as a finalized "Version of Record" establishes the expectation that it can be relied upon as accurate, complete, and citable. Journal of Pharmaceutical Research & Reports defines this Version of Record as the initial article publication for open access journals.

It is presumed that manuscripts report on work based on honest observations. However occasionally information becomes available with may contradict this. In such situations Scientific Research and Community Publishing journals apply Committee on Publication Ethics guidelines on corrections, retractions and expressions of concern.


Corrections
Errors in published papers may be identified requiring publication of a correction in the form of a corrigendum or erratum. Because articles can be read and cited as soon as they are published, any changes thereafter could potentially impact those who read and cited the earlier version. Journal of Pharmaceutical Research & Reports provides authors with an opportunity to review article proofs prior to publication with the express goal of ensuring accuracy of the content. Publishing an erratum or corrigendum increases the likelihood readers will find out about the change and also explains the specifics of the change.

Corrigenda and Errata are published on a numbered page and will contain the original article's citation. Cases where these corrections are insufficient to address an error will be dealt with on a case-by-case basis by the Editor in Chief. Inadequacies arising from the normal course of new scientific research are not within the scope of this and will require no correction or withdrawal.

Expressions of Concern

Where substantial doubt arises as to the honesty or integrity of a submitted or published article it is the Editor in Chief's responsibility to ensure that the matter is adequately addressed, usually by the authors' sponsoring institution. It is not normally the Editor in Chief's responsibility to carry out the investigation or make a determination. The Editor in Chief should be promptly informed of the decision of the sponsoring institution and a retraction printed should it be determined that a fraudulent paper was published. Alternatively, the Editor in Chief may choose to publish an expression of concern over aspects of the conduct or integrity of the work.

Article Withdrawal

Articles may be withdrawn by corresponding author before accepting for publication. If it is accepted, it could be used only for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Articles in Press (articles that have been accepted for publication but which have not been formally published and will not yet have the complete volume/issue/page information) that include errors, or are discovered to be accidental duplicates of other published article(s), or are determined to violate our journal publishing ethics guidelines in the view of the editors (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), may be "Withdrawn" from Journal of Pharmaceutical Research & Reports. Articles which have been published under an issue could not be withdrawn and there would be withdrawal charges of USD 559.

Article Retraction

Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication. The retraction of an article by its authors or the editor under the advice of members of the scholarly community has long been an occasional feature of the learned world. Standards for dealing with retractions have been developed by a number of library and scholarly bodies, and this best practice is adopted for article retraction by Journal of Pharmaceutical Research & Reports:
- A retraction notes titled "Retraction: [article title]" signed by the authors and/or the editor is published in the paginated part of a subsequent issue of the journal and listed in the contents list.
- In the electronic version, a link is made to the original article.

- The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves, the reader can then proceed to the article itself.

- The original article is retained unchanged save for a watermark on the .pdf indicating on each page that it is "retracted".

- The HTML version of the document is removed.

Article Removal: Legal Limitations
In an extremely limited number of cases, it may be necessary to remove an article from the online database. This will only occur where the article is clearly defamatory, or infringes others' legal rights, or where the article is, or we have good reason to expect it will be, the subject of a court order, or where the article, if acted upon, might pose a serious health risk. In these circumstances, while the metadata (Title and Authors) will be retained, the text will be replaced with a screen indicating the article has been removed for legal reasons.

Article Replacement

In cases where the article, if acted upon, might pose a serious health risk, the authors of the original article may wish to retract the flawed original and replace it with a corrected version. In these circumstances the procedures for retraction will be followed with the difference that the database retraction notice will publish a link to the corrected re-published article and a history of the document.

Reprints
Reprints may be purchased. Order for supply of reprints may be sent while returning the galley proofs after corrections. No reprint/s will be supplied free of charge. Reprint Order Form and Price List will be sent with the galley proofs.

Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (http://www.who.int/bulletin/archives/79(4)373.pdf). Do not use patients' names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council's guide for, or any national law on the care and use of laboratory animals was followed.

Annual Subscription
Euro € 3600.00 for Single Volume, € 600.00 for Single Issue (+postage charge €100)